You have 9 free searches left this month | for more free features.

Condition

Acellular Pertussis (1)

Coronavirus Infection (1)

Diphtheria (1)

Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines (1)

Multiple Myeloma (1)

Poliomyelitis (1)

SARS-CoV2 Infection (1)

Tetanus (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 4 (2)

phase 2 (1)

Sponsor

GlaxoSmithKline (1)

Mark Loeb (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Collaborator

Aduro Biotech, Inc. (1)

Celgene (1)

Intervention

prevnar13 (3)

gm-csf vaccine (1)

infanrix hexa (1)

lenalidomide (1)

mrna- covid-19 (1)

placebo gm-csf vaccine (1)

placebo prevnar13 (1)

Study Documents

Intervention Type

drug (3)

biological (2)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

prevnar13

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma Trial in Baltimore (biological, drug, other)

Recruiting

Multiple Myeloma

GM-CSF vaccine
+4 more

Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Jan 6, 2022

SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)

Not yet recruiting

SARS-CoV2 Infection
Coronavirus Infection

mRNA- COVID-19
Prevnar13

Hamilton, Ontario, Canada

McMaster University

Jun 29, 2022

Acellular Pertussis, Tetanus, Poliomyelitis Trial in Worldwide (Infanrix hexa, Prevnar13)

Completed

Has Results

Acellular Pertussis
+4 more

Infanrix hexa
Prevnar13

Carlton, Victoria, Australia
+29 more

Jun 26, 2019